Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal analgesics.

Hollie Nguyen1, Jason E Garber, Samuel J Hassenbusch

  • 1Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 442, Houston, TX 77030, USA.

Anesthesiology Clinics of North America
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrathecal bupivacaine for chronic pain: a review of current knowledge.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Refractory insomnia in a patient with spinal cord stimulator lead migration.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Practice choices and challenges in the current intrathecal therapy environment: an online survey.

Pain medicine (Malden, Mass.)·2009
Same author

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.

Neuro-oncology·2007
Same author

Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.

American journal of clinical oncology·2007
Same journal

Cumulative Index 2004.

Anesthesiology clinics of North America·2020
Same journal

Infectious Disease and Bioterrorism.

Anesthesiology clinics of North America·2020
Same journal

CONTENTS.

Anesthesiology clinics of North America·2020
Same journal

Index.

Anesthesiology clinics of North America·2020
Same journal

Pediatric anesthesiology: thoughts on the future.

Anesthesiology clinics of North America·2005
Same journal

Palliative care in pediatrics.

Anesthesiology clinics of North America·2005
See all related articles

Developing novel analgesics for intrathecal administration requires evaluating antinociceptive efficacy, spinal cord safety, drug stability, and pump compatibility. Pharmaceutical investment is crucial for FDA approval and commercialization.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Development

Background:

  • Intrathecal drug administration offers targeted pain relief.
  • Novel analgesics require rigorous evaluation before clinical use.

Purpose of the Study:

  • To outline key considerations for the intrathecal administration of novel analgesics.
  • To identify critical factors for successful development and regulatory approval.

Main Methods:

  • Review of essential properties for intrathecal drug candidates.
  • Assessment of safety, stability, and compatibility requirements.

Main Results:

  • Antinociceptive efficacy and spinal cord safety are paramount.
  • Drug stability, solubility, and pump compatibility are critical for implanted systems.

Related Experiment Videos

  • Pharmaceutical investment and FDA approval pathways are essential for commercialization.

    • Conclusions:

    • Successful intrathecal analgesic development hinges on a multifaceted approach.
    • Addressing efficacy, safety, formulation, and commercial viability is necessary.